ArticleFrontiers in endocrinology2026
Super-resolution ultrasound radiomics for pre-FNA prediction of nondiagnostic (Bethesda I) thyroid nodules.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: We evaluated whether a generative adversarial network (GAN)-based super-resolution (SR) radiomics pipeline could improve the pre-fine-needle aspiration (FNA) prediction of nondiagnostic (Bethesda I) outcomes in thyroid nodules compared with normal-resolution (NR) ultrasound analysis. Methods: This single-center retrospective study included 437 patients with thyroid nodules, with 338 assigned to the development cohort and 99 to a temporally independent validation cohort. Two-dimensional B-mode ultrasound images were processed using a pretrained GAN-based SR model in inference-only mode. Handcrafted radiomic features were extracted using PyRadiomics and subjected to a multistep selection pipeline comprising the Mann-Whitney U test, Spearman correlation-based redundancy pruning, random forest-based recursive feature elimination (RFE), and least absolute shrinkage and selection operator (LASSO) regression. Four machine-learning classifiers, including random forest (RF), LightGBM, ExtraTrees, and XGBoost, were trained using five repeated stratified 80/20 splits. Post hoc probability calibration was performed using Platt (sigmoid) scaling fitted on the training set and applied unchanged to the independent validation set. In addition, qualitative error analysis was conducted to characterize false-positive and false-negative cases and to assess the potential effect of operator experience on model performance. Results: The SR-based models consistently outperformed the NR-based models. The SR-RF model achieved an area under the receiver operating characteristic curve (AUC) of 0.808 in training and 0.733 in internal testing, compared with 0.672 and 0.596, respectively, for the NR-RF model. In the independent validation cohort, the SR-RF model yielded an AUC of 0.7435. Platt calibration improved the Brier score from 0.1885 to 0.1702 without affecting AUC, indicating improved probability reliability. Across classifiers, RF and LightGBM showed the most balanced overall performance. Qualitative error analysis showed that false-positive cases were often associated with cystic or heterogeneous echotexture and posterior acoustic artifacts, whereas false-negative cases involved isoechoic solid nodules with subtle margins and limited region-of-interest (ROI) coverage. No systematic effect of operator experience on model performance was observed. Discussion: GAN-based SR radiomics significantly improves the pre-FNA prediction of nondiagnostic cytology in thyroid nodules. When combined with post hoc calibration, this approach provides more reliable individualized risk estimates and may help reduce unnecessary repeat procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.